📅Offer Date: 19 Feb 2024 – 22 Feb 2024
Data sourced from BSE & NSE · Last updated
Zenith Drugs Limited IPO was subscribed 179.07x in total when bidding closed on 22 Feb 2024, with 0.00x in the QIB category, 0.00x in NII, 138.57x in retail. The issue ran from 19 Feb 2024 to 22 Feb 2024 at a price band of ₹75.00–₹79.00 per share.
Times subscribed by category against the 1× line.
Based on retail subscription (138.57x). Final allotment decided by registrar's computerised lottery.
| Category | Offer | Applied | Times |
|---|---|---|---|
| Retail | 15,04,000 | 20,84,09,280 | 138.57x |
| Total | 30,08,000 | 53,86,42,560 | 179.07x |
| QIB / NII | 8,59,200 | 0 | 0.00x |
| Category | Offered | Demand | Times |
|---|---|---|---|
| Retail | 11.88 | 1646.43 | 138.57x |
| QIB / NII | 6.79 | — | 0.00x |
| Total | 18.67 | 1646.43 | 179.07x |
Values derived from share count × issue price (₹79.00)
Because Zenith Drugs Limited closed oversubscribed, allotment follows the applicable category and exchange rules. A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice.
NSE SME listed · Bidding data sourced from BSE & NSE under SEBI ICDR regulations.